INT125711

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.51
First Reported 2002
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 6
Total Number 7
Disease Relevance 3.64
Pain Relevance 0.12

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

TSS (Mus musculus)
Pain Link Frequency Relevance Heat
pruritus 6 90.88 High High
cINOD 1 71.12 Quite High
Neuropathic pain 6 50.00 Quite Low
Pain 4 10.00 Low Low
Inflammation 30 5.00 Very Low Very Low Very Low
corticosteroid 15 5.00 Very Low Very Low Very Low
Antihistamine 10 5.00 Very Low Very Low Very Low
agonist 10 5.00 Very Low Very Low Very Low
complementary and alternative medicine 10 5.00 Very Low Very Low Very Low
cytokine 7 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Septic Shock 24 100.00 Very High Very High Very High
Syndrome 6 95.48 Very High Very High Very High
Wheal 29 92.24 High High
Pruritus 15 90.88 High High
Streptococcal Infections 1 87.80 High High
Urticaria 75 86.24 High High
Cellulitis 1 79.72 Quite High
Disease 25 77.36 Quite High
Rhinitis 47 75.00 Quite High
Pressure Volume 2 Under Development 1 73.68 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
An oral or intravenous alpha lipoic dose of at least 600 mg per day resulted in a 50% reduction in the TSS.
Negative_regulation (reduction) of TSS
1) Confidence 0.51 Published 2010 Journal Neth J Med Section Body Doc Link 20421656 Disease Relevance 0.07 Pain Relevance 0
However, compared with the control group, the TSS reduction in most groups was less than 30%, which is the threshold presumed to be clinically relevant.
Negative_regulation (reduction) of TSS
2) Confidence 0.51 Published 2010 Journal Neth J Med Section Body Doc Link 20421656 Disease Relevance 0.07 Pain Relevance 0
Changes in the manufacturing and use of tampons led to a decline in staphylococcal TSS over the past decade, while the incidence of nonmenstrual staphylococcal TSS increased.
Negative_regulation (decline) of TSS associated with septic shock
3) Confidence 0.36 Published 2005 Journal Paediatr Drugs Section Abstract Doc Link 15777108 Disease Relevance 2.63 Pain Relevance 0.07
Results: Post-treatment, the reduction in TSS over baseline with PQ was significantly larger (-6.61) than with placebo (-4.47) (p = .007).
Negative_regulation (reduction) of TSS
4) Confidence 0.11 Published 2007 Journal Allergy Asthma Clin Immunol Section Body Doc Link PMC2875553 Disease Relevance 0.05 Pain Relevance 0
There was a 4.85% decrease in the TSS of the loratadine group, in comparison to 13.32% in the levocetirizine group.
Negative_regulation (decrease) of TSS
5) Confidence 0.04 Published 2010 Journal Indian Journal of Pharmacology Section Body Doc Link PMC2885633 Disease Relevance 0.48 Pain Relevance 0.05
There was a 4.85% decrease in TSS in the loratadine group as compared to 13.32% in the levocetirizine group.
Negative_regulation (decrease) of TSS
6) Confidence 0.04 Published 2010 Journal Indian Journal of Pharmacology Section Body Doc Link PMC2885633 Disease Relevance 0 Pain Relevance 0
This dosing range also was significantly (P < .01) more effective than placebo for reducing AM instantaneous TSS beginning with the first dose; thus, demonstrating the full 24-hour efficacy of desloratadine.
Negative_regulation (reducing) of TSS
7) Confidence 0.03 Published 2002 Journal BMC Fam Pract Section Abstract Doc Link PMC122063 Disease Relevance 0.33 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox